期刊
CELL CYCLE
卷 2, 期 2, 页码 99-104出版社
TAYLOR & FRANCIS INC
DOI: 10.4161/cc.2.2.332
关键词
Cyclin; Cyclin-dependent kinsase; Heart; Transcription
类别
A subset of cyclin-dependent protein kinases-Cdk7, Cdk8, and Cdk9-participates directly, in complex ways, with the fundamental machinery for gene transcription, as elements of general transcription factors whose substrate is the C-terminal domain (CTD) of RNA polymerase II. Here, we review recent data implicating the CTD kinase Cdk9 as a critical determinant of cardiac hypertrophy, in vitro and in vivo. Diverse trophic signals that increase cardiac mass all activated Cdk9 (work load, the small G-protein G alpha q, and the calcium-dependent phosphatase calcineurin in mouse myocardium; endothelin-1, a hypertrophic agonist, in cultured cardiomyocytes). Little or no change occurred in levels of the kinase or its activator, cyclin T. Instead, in all four hypertrophic models, Cdk9 activation involves the dissociation of 7SK small nuclear RNA (snRNA), an endogenous inhibitor. In culture, dominant-negative Cdk9 blocked ET-1-induced hypertrophy, whereas an anti-sense knockdown of 7SK snRNA provoked spontaneous cell growth. In transgenic mice, concordant with these results, activation of Cdk9 activity via cardiac-specific overexpression of cyclin T1 suffices to provoke hypertrophy. Together, these findings implicate Cdk9 activity as a pivotal regulator of pathophysiological heart growth. Because hypertrophy, in turn, is a cardinal risk factor for developing cardiac pump failure, these results support the logic of examining Cdk9 as a potential drug target in heart disease.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据